• CYFRA 21-1 (Cytokeratin 19 Fragment), Serum
  • Nephroblastoma (Wilms tumor)
  • Histoplasma capsulatum Antigen, Serum
  • Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) Genotyping
  • Interferon B-1 (IFNB-1) Neutralizing Antibody
  • HDL Cholesterol Subclasses
  • MSK-IMPACTâ„¢, Solid Organ Gene Cancer Panel
  • Klippel-Trenaunay Syndrome
  • Complement Component C1q
  • Sex Hormone Binding Globulin (SHBG)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Human Papillomavirus (HPV), High-Risk, DNA In Situ Hybridization
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Human Papillomavirus (HPV), High-Risk, DNA In Situ Hybridization
Medical Test

Turnaround Time
Access to Human Papillomavirus (HPV), High-Risk, DNA In Situ Hybridization is restricted.